Back to Point72 Asset Management, L.P. Point72 Asset Management, L.P.

CYTKCYTK
Showing 8 of 29 quarters

Position history for Point72 Asset Management, L.P.Point72 Asset Management, L.P.'s holdings in CYTOKINETICS INC

Point72 Asset Management, L.P. holds 1.6M shares of CYTK (CYTOKINETICS INC), worth $135.3M as of 2026-Q2. The position was increased (+153.6% shares). CYTK represents 0.1% of Point72 Asset Management, L.P.'s portfolio.

Current Value

$135.3M

Current Shares

1.6M

Total Value Change

+$110.8M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.6M
+153.6%
$135.3M0.1%$85.19
58
2026-Q1
New
626,102
-
$41.3M0.1%$65.91
40
2025-Q4
Exited
0
-100.0%
$00.0%$63.54
0
2025-Q3
New
471,482
-
$25.9M0.0%$54.96
40
2025-Q2
Exited
0
-100.0%
$00.0%$33.04
0
2025-Q1
Increased
1.7M
+914.0%
$69.2M0.2%$40.19
57
2024-Q4
Decreased
169,913
-63.4%
$8M0.0%$47.04
0
2024-Q3
Increased
464,010
+23.8%
$24.5M0.1%$52.80
35

Other major holders of CYTK: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used